‘Overpriced’ Antifungal Drug Seized In Kothagudem

Hyderabad: As part of stepped-up surveillance against overcharging of essential medicines, the Drugs Control Administration (DCA), Telangana, officials have seized ‘overpriced’ antifungal drug ‘GRISOLAB-250’ Griseofulvin tablets-250 mg during a surprise check in Kothagudem on Tuesday.

The worth of the stock seized during the raid is ₹4,095, according to a press release. The seized product, manufactured by Laborate Pharmaceuticals India Ltd, Himachal Pradesh, and marketed by Gpp Axalade, Salwan, Haryana, bears MRP as ₹65 for 10 tablets on the label of the product, which is a violation of Drugs (Prices Control) Order, 2013, the press release added. The ceiling price fixed by the Central government for the product ‘Griseofulvin tablets-250 mg’ is ₹17.7 for 10 tablets. Hence, the MRP i.e., including GST 12% should not be more than ₹19.83 for 10 tablets.

However, the pharmaceutical firm ‘overpriced’ the product. A strip of tablets has been charged excess of ₹45.17 per 10 tablets. Further investigation into the matter is underway and action will be taken against all the offenders as per the law, the DCA officials said.

In a separate incident, the DCA sleuths raided a medical shop named ‘Amaan Medical and General Stores’ allegedly operating without drug licence at Jaklair village in Narayanpet district. The officials seized an unauthorised stock of medicines including antibiotic injections, IV fluids, analgesics, antihypersensitive drugs and cough syrups worth ₹ 1.20 lakh. Further investigation is in progress.

Related Posts

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

AiMeD welcomes, also offering help design a Uniform National Framework for Holistic Transparency New Delhi/ Bangalore: Central government and Karnataka government have initiated measures to bring about greater transparency in…

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day